Based on our previous study regarding the putative antipsychotic-like activity of mGlu7 NAMs [7], we aimed to assess the efficacy of newly synthesized compounds to reverse schizophrenia-like symptoms in several behavioral tests. The gene discussed is GRM7; the disease is schizophrenia.